Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.78
+0.0800 (+1.70%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Jul 25, 2023 $0.653 $0.690 $0.643 $0.656 65 091
Jul 24, 2023 $0.670 $0.680 $0.653 $0.663 92 314
Jul 21, 2023 $0.770 $0.770 $0.642 $0.668 443 384
Jul 20, 2023 $0.687 $0.687 $0.630 $0.648 117 515
Jul 19, 2023 $0.620 $0.680 $0.620 $0.663 31 705
Jul 18, 2023 $0.669 $0.681 $0.640 $0.651 48 761
Jul 17, 2023 $0.630 $0.714 $0.562 $0.681 186 215
Jul 14, 2023 $0.720 $0.720 $0.623 $0.630 373 623
Jul 13, 2023 $0.650 $0.83 $0.650 $0.719 4 098 002
Jul 12, 2023 $0.590 $0.630 $0.590 $0.611 78 484
Jul 11, 2023 $0.571 $0.598 $0.570 $0.598 28 918
Jul 10, 2023 $0.573 $0.590 $0.550 $0.570 35 746
Jul 07, 2023 $0.580 $0.590 $0.550 $0.568 32 109
Jul 06, 2023 $0.550 $0.586 $0.540 $0.572 41 624
Jul 05, 2023 $0.580 $0.592 $0.550 $0.550 42 912
Jul 03, 2023 $0.590 $0.598 $0.549 $0.574 147 949
Jun 30, 2023 $0.535 $0.580 $0.535 $0.579 91 111
Jun 29, 2023 $0.535 $0.560 $0.535 $0.556 15 869
Jun 28, 2023 $0.589 $0.598 $0.530 $0.540 123 662
Jun 27, 2023 $0.573 $0.575 $0.532 $0.561 55 086
Jun 26, 2023 $0.550 $0.578 $0.520 $0.570 238 154
Jun 23, 2023 $0.599 $0.600 $0.540 $0.540 115 714
Jun 22, 2023 $0.580 $0.600 $0.560 $0.600 52 132
Jun 21, 2023 $0.575 $0.630 $0.570 $0.597 128 677
Jun 20, 2023 $0.560 $0.600 $0.560 $0.570 63 874
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT